CMALX
Price
$26.62
Change
-$0.10 (-0.37%)
Updated
Jun 13 closing price
Net Assets
143.74M
RLBCX
Price
$35.41
Change
-$0.31 (-0.87%)
Updated
Jun 13 closing price
Net Assets
244.39B
Interact to see
Advertisement

CMALX vs RLBCX

Header iconCMALX vs RLBCX Comparison
Open Charts CMALX vs RLBCXBanner chart's image
Crawford Multi-Asset Income
Price$26.62
Change-$0.10 (-0.37%)
VolumeN/A
Net Assets143.74M
American Funds American Balanced R3
Price$35.41
Change-$0.31 (-0.87%)
VolumeN/A
Net Assets244.39B
CMALX vs RLBCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CMALX vs. RLBCX commentary
Jun 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CMALX is a Buy and RLBCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBCX has more cash in the bank: 244B vs. CMALX (144M). CMALX pays higher dividends than RLBCX: CMALX (3.99) vs RLBCX (1.63). CMALX was incepted earlier than RLBCX: CMALX (8 years) vs RLBCX (23 years). CMALX (1.24) is less costly to investors than RLBCX (0.89). RLBCX is a more actively managed with annual turnover of: 44.00 vs. CMALX (19.00). RLBCX has a lower initial minimum investment than CMALX: RLBCX (250) vs CMALX (10000). CMALX annual gain was more profitable for investors over the last year : 10.91 vs. RLBCX (4.94). CMALX return over 5 years is better than : 55.16 vs. RLBCX (36.51).
CMALXRLBCXCMALX / RLBCX
Total Expense Ratio1.000.89112%
Annual Report Gross Expense Ratio1.240.89139%
Fund Existence8 years23 years-
Gain YTD2.4014.29456%
Front LoadN/AN/A-
Min. Initial Investment100002504,000%
Min. Initial Investment IRAN/AN/A-
Net Assets144M244B0%
Annual Yield % from dividends3.991.63244%
Returns for 1 year10.914.94221%
Returns for 3 years24.5231.5478%
Returns for 5 years55.1636.51151%
Returns for 10 yearsN/A54.99-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MLTX44.210.19
+0.43%
MoonLake Immunotherapeutics
NOVA0.22N/A
N/A
Sunnova Energy International
XTNT0.62-0.03
-4.23%
Xtant Medical Holdings
FND73.63-3.40
-4.41%
Floor & Decor Holdings
EZGO0.36-0.02
-4.65%
EZGO Technologies Ltd